MTM + CHW Support for Type 2 Diabetes
(ENRxICH Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
The purpose of the study is to learn about the best way to enhance pharmacy-related care for diabetes self-management.This research is being done because we want to improve use of medicines and diabetes management among adults with type 2 diabetes and find out which of type of support may improve diabetes self-management for adults.Participants will be assigned to one of 4 groups, and will either:* receive care as usual; or,* receive added medicine management support from a pharmacist; or,* receive support from a Community Health Worker (CHW) to address life challenges; or,* receive both the pharmacist medicine management and the CHW support
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It seems likely that you will continue your current diabetes medications, as the study aims to improve medication management.
Is the combination of MTM and CHW support safe for humans?
How does the MTM + CHW Support treatment for type 2 diabetes differ from other treatments?
The MTM + CHW Support treatment is unique because it combines medication therapy management (MTM) with the support of community health workers (CHWs), who help patients manage their diabetes through education and lifestyle interventions. This approach leverages the trust and accessibility of CHWs to improve diabetes self-management, especially in underserved communities, which is not typically a focus of standard diabetes treatments.12567
What data supports the effectiveness of the treatment CHW, MTM for Type 2 Diabetes?
Who Is on the Research Team?
Michelle Chui, PharmD, PhD
Principal Investigator
University of Wisconsin, Madison
Are You a Good Fit for This Trial?
This trial is for Black and Hispanic adults aged 18-90 with type 2 diabetes, who speak English or Spanish. They must live in the study area, have a phone, take diabetes medication from the study pharmacy, and have an HbA1c of at least 8%. They can't join if they've had similar medicine management support recently or are in another program.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive one of four interventions: usual care, Medication Therapy Management (MTM), Community Health Worker (CHW) support, or both MTM and CHW support for 6 months
Follow-up
Participants are monitored for changes in medication adherence and HbA1c levels
Long-term follow-up
Participants' medication adherence and HbA1c levels are assessed at 12 months
What Are the Treatments Tested in This Trial?
Interventions
- CHW
- MTM
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Wisconsin, Madison
Lead Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborator